Regulatory Safety Updates
Daily changes from official regulators: safety signals, DHPCs, restrictions, recalls, risk-management plans and product-information updates.
Five medicine quality recalls and restrictions — 19 August 2026
Quality defects affecting specific batches of ketorolac, rifampicin, linezolid, troxerutin and calcium gluconate, including abnormal toxicity, mechanical inclusions and bacterial endotoxins.
Read the full updateNine medicine safety updates — 18 August 2026
Ipidacrine liver-injury review; recalls involving contamination, particulates and a strength mix-up; ARIA precautions and three apixaban bleeding-risk minimisation packages.
Read the full updateFour medicine safety updates — 15 August 2026
Three recalls of injectable medicines for impurities or particles and a Temozolomide Accord recall due to a potential double dose.
Read the full updateThree Medicine Safety Updates — 14 August 2026
Tyenne recall for glass particles, a pms-IRBESARTAN tablet mix-up and extended contraception after CellCept.
Read the full updateRoszdravnadzor recalls salicylic-zinc paste batch over pH nonconformity
Batch 010326 is being withdrawn after a pH nonconformity; the official notice cites measures to eliminate risks to life and health.
Read the full updateTwo Medicine Safety Updates: Meningioma Risk and Falsified DARZALEX
Meningioma risk with desogestrel/etonogestrel and WHO warning on falsified DARZALEX batches.
Read the full updateTen Important Medicine Safety Updates — 11 August 2026
Ten confirmed topics covering new warnings, severe adverse reactions and risk-minimisation measures.
Read moreFive New Medicine Recalls in the United States and Russia — 10 August 2026
Five officially confirmed medicine recalls associated with documented patient-safety risks.
Read the full update3 Important Drug Safety Updates — 3 August 2026
Three newly verified medicine-safety developments from official regulatory sources.
Read the full updateUzbekistan: Additional Monitoring of Medicines
Requirements for black inverted-triangle labelling and prompt adverse-reaction reporting.
Read the full update6 Important Drug Safety Updates — 28 July 2026
Six relevant safety updates selected from official regulator publications.
Read the full updateNo publications match the selected filters.
PharmExpert monitors official regulatory sources daily and distinguishes confirmed facts from items requiring primary-document verification.